๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

237 Progression of Advanced Chronic Hepatitis C (CHC): Further Follow-up Results From the Halt-C Trial

โœ Scribed by Dienstag, Jules L.; Bonkovsky, Herbert L.; Kim, Hae-Young; Seeff, Leonard B.; Di Bisceglie, Adrian M.; Szabo, Gyongyi; Wright, Elizabeth C.

Book ID
122909793
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
99 KB
Volume
138
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Evolution of hepatic steatosis in patien
Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
โœ Anna S. Lok; James E. Everhart; Raymond T. Chung; Hae-Young Kim; Gregory T. Ever ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 404 KB ๐Ÿ‘ 2 views

Hepatic steatosis is a common histologic feature in patients with chronic hepatitis C (CHC) but there are no large longitudinal studies describing the progression of steatosis in CHC. We examined changes in steatosis on serial biopsies among CHC patients participating in the Hepatitis C Antiviral Lo

A prospective study of the rate of progr
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C
โœ Jules L. Dienstag; Marc G. Ghany; Timothy R. Morgan; Adrian M. Di Bisceglie; Her ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 431 KB ๐Ÿ‘ 1 views

The incidence of liver disease progression among subjects with histologically advanced but compensated chronic hepatitis C is incomplete. The Hepatitis C Antiviral Long-term Treatment against Cirrhosis Trial was a randomized study of 3.5 years of maintenance peginterferon treatment on liver disease